Double-Blind Placebo-Controlled Trial of Methylphenidate in the Treatment of Adult ADHD Patients With Comorbid Cocaine Dependence.

  • Schubiner H
  • Saules K
  • Arfken C
 et al. 
  • 4


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


In this 12-week double-blind placebo-controlled trial of methylphenidate (MTP) versus placebo in 48 cocaine-dependent attention-deficit/hyperactivity disorder (ADHD) adults, the authors sought to determine whether MTP would be safe, control ADHD symptoms, and affect cocaine use. Efficacy indexes revealed significantly greater ADHD symptom relief in the MTP group. There were no group differences in self-reported cocaine use, urinalysis results, or cocaine craving. Because of the relatively small sample size, the results are preliminary. However, we found that MTP improved subjective reports of ADHD symptoms and did not worsen cocaine use while participants were in treatment., (C) 2002 by the American Psychological Association

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Howard Schubiner

  • Karen Saules

  • Cynthia Arfken

  • Chris-Ellyn Johanson

  • Charles Schuster

  • Nancy Lockhart

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free